Now I have a clear picture. Let me synthesize the final review.

**Calibration comparison summary:**

| Anchor | Score | Comparison to submission |
|--------|-------|--------------------------|
| JQtuCumAFD (Davidov et al. 2025) — R1 | 5.50 | Submission clearly extends this with counterfactual setting, exact guarantees, doubly robust theory, outlier experiment. Submission is meaningfully stronger. |
| pVL4bYKOGM (CP for causal effects of continuous treatments) — R1 | 5.50 | Submission has stronger empirical validation and clearer theory; submission is stronger. |
| AKAz88zYLB (CP for dose-response) — R1/R2 | 5.80 | Both are causal+CP papers; submission has better empirical story. Submission is above this. |
| Nfd7z9d6Bb (Probabilistic CP, approx conditional) — R1/R2 | 6.00 | Comparable theoretical polish, but submission has bolder empirical results. Roughly comparable. |
| 4vPVBh3fhz (PAC prediction sets under label shift) — R2 | 6.40 | Cleaner theory and presentation; submission's Eq(1) issue makes it weaker than this anchor. |
| aJ3tiX1Tu4 (Wasserstein-regularized CP) — R2 | 6.67 | More theoretically sophisticated; submission is clearly below this level. |

**Bracket: 5.5–7.0 → narrowed to 5.8–6.4. Final: 6.0.**

The submission is above Davidov et al. (5.50) and the dose-response CP paper (5.80), comparable to the probabilistic CP paper (6.00), but below the more polished PAC/Wasserstein CP papers (6.40, 6.67). Score: **6.0**. Decision: **Accept** (the baseline Davidov paper was accepted at 5.50, and this paper adds non-trivial contributions).

---

## Summary
This paper proposes a conformal prediction procedure for constructing lower prediction bounds (LPBs) on counterfactual survival times under different treatments with general right-censored data. The method uses importance-weighted conformal prediction, where the weights correct for the distribution shift from the full covariate population to the subpopulation with observed events. The authors provide a coverage bound that decomposes into nominal level minus weight estimation error (Theorem 4.1), a doubly robust asymptotic property (Theorem 4.2), and empirical validation on synthetic data (six settings, outlier robustness, multi-treatment) and a real NSCLC clinical dataset.

## Strengths
- **Reweighting derivation (Equation 1)**: The transformation that converts the counterfactual survival coverage problem into a weighted conformal inference problem over the uncensored, treated subset is a genuine technical contribution. This avoids the empirical-approximation step that forces PAC-type guarantees in prior work (Gui et al., 2024; Davidov et al., 2025).
- **Explicit error quantification (Theorem 4.1)**: The non-asymptotic bound ℙ(T(w) ≥ L̃(X)) ≥ 1 − α − ½𝔼[|ω̃(X) − ω(X)|] cleanly decomposes coverage into nominal level minus L1 weight estimation error, with a normalization step providing practical stabilization.
- **Doubly robust property (Theorem 4.2)**: Asymptotic coverage holds if either the weight function or the quantile regression is well-estimated, providing robustness against misspecification of one component. The additional conditional coverage result (Equation 7) goes beyond marginal guarantees.
- **Outlier robustness experiment (Figure 3)**: The method maintains ~90% coverage under increasingly severe outlier contamination (N(1,2), N(10,2), N(20,2)) while Davidov et al. (2025)'s Focus and Fused methods degrade to as low as ~78%. This directly validates the practical advantage of marginal guarantees over PAC-type alternatives — arguably the paper's most persuasive piece of evidence.
- **Clinically meaningful adaptiveness (Figures 4–5)**: On 541 NSCLC patients, the LPB correlates sensibly with known prognostic factors (stage, KPS, tumor dimensions), VMAT shows higher LPB than IMRT (consistent with Hunt et al., 2022), and induction/concurrent chemotherapy show higher LPBs (consistent with Aguado et al., 2022).
- **General right-censoring without requiring observed censoring times**: Unlike Candès et al. (2023) and Gui et al. (2024), the method does not need C_i to be observed, extending applicability to realistic clinical scenarios.

## Weaknesses

### Fatal
None.

### Major
- **Equation (1), step (ii) is mathematically unjustified as written.** The derivation multiplies ℙ(T ≤ … | X, W) by 1/p(e=1 | X, W) and attributes this to "the tower property" (line 140). The tower property does not justify multiplying a conditional probability by an arbitrary factor — this step is not generally an equality. The intended derivation likely involves rewriting via the law of total probability as ℙ(T ≤ …, e=1 | X, W)/p(e=1 | X, W) followed by an inequality, but as presented the chain is incorrect. Since this derivation is the foundation of the entire method, it must be corrected and clarified. (Note: this criticism does not depend on the stripped appendix; the issue is with what is presented in the main text.)

### Minor
- **"Exact" framing overstates what is proved.** The paper repeatedly uses "exact" (abstract, lines 9, 28, 33, 44, 92, 112, 178) to contrast with PAC-type guarantees. But Theorem 4.1 shows coverage depends on weight estimation error ½𝔼[|ω̃(X) − ω(X)|]. With imperfect weight estimation, the guarantee is approximate. The paper does acknowledge this qualification in places (line 28: "provided that the weight function can be well estimated"; line 33: "quantify the error from weight estimation"), but the abstract and headline claims should more precisely characterize what "exact" means — it is exact in the sense of avoiding the PAC empirical-approximation error, but not exact in the sense of being free of all estimable error terms.
- **τ-optimization lacks theoretical justification.** Section 4.1 chooses τ*(x) = arg max_τ(q̃_τ(x) − c(τ)(x)) per test point, claiming validity "for any τ" (line 162). Theorem 4.1 is stated for a fixed quantile level α, not for data-adaptively chosen τ. Coverage guarantees for a fixed score function do not automatically extend to a score function optimized per test point. The paper should either provide theoretical justification or acknowledge this as a heuristic validated empirically.
- **No baseline comparisons on real clinical data.** Section 5.2 (Figures 4–5) reports only the proposed method's performance on the NSCLC dataset. There is no comparison to Davidov et al. (2025) or any other baseline. Treatment superiority claims (VMAT > IMRT) are drawn from inspecting LPB values from a single method, which is methodologically insufficient.
- **Undefined baselines and metrics in the main text.** "Uncal" (uncalibrated) and "Naive" methods are mentioned (line 236) without formal definitions of their calibration procedures. "Relative LPB" — the primary evaluation metric across all figures — is never explicitly defined. Readers cannot fully interpret the experimental results without these definitions.

### Trivial
- **Notation inconsistency between τ and α.** The method uses τ as the quantile level parameter to optimize (Algorithm 1, line 83), while Theorem 4.1 is stated in terms of α. The relationship between τ, α, and the coverage guarantee should be clarified.
- Theorem 4.2's conditions (A2(i)-(ii)) are stated technically but not discussed interpretably — the reader cannot easily assess when they hold in practice.

## Nice-to-Haves
- An empirical estimate of the weight estimation error ½𝔼[|ω̃(X) − ω(X)|] would connect the theory to the experiments and quantify how close the method is to exact coverage.
- A brief summary of the synthetic data generating process in the main text would let readers assess the six settings without consulting the appendix.
- Adding at least one baseline comparison on the real clinical dataset would substantially strengthen the empirical case for the method's practical advantage.

## Removed Points
These points are flagged to be removed, treat them with caution.

- **Harsh Critic: "The paper does not discuss exchangeability, which is the core assumption of conformal prediction."** → REMOVED. The i.i.d. assumption is clearly stated (line 52: "(W_i, X_i, T_i(1), T_i(0), e_i) i.i.d. ∼ ℙ") and data splitting is standard in conformal prediction; the weighted CP framework from Lei & Candès (2021) handles the covariate shift, making separate discussion of exchangeability unnecessary.
- **Harsh Critic: "The derivation references Lemma A.1 (which was stripped by the parser)"** → The core criticism about step (ii) stands on its own regardless of the missing lemma. The missing-appendix aspect is a parser artifact and is not held against the paper.
- **Strength Finder: "LPB optimization via τ*(x) selection maximizes informativeness while maintaining coverage for any τ"** → REMOVED as a strength because the τ-optimization's validity is not theoretically established (see Minor weakness above).
- **Strength Finder: Generic framing strengths about "important problem" / "interesting question"** → REMOVED per instructions as superficial.
- **Harsh Critic: "The paper would need either to achieve a true exact guarantee or to characterize its contribution honestly"** → REMOVED. This is scope-creep demanding a different contribution. The paper's approach of quantifying the error term is a legitimate contribution strategy; the issue is the imprecise "exact" framing, not the approach itself.
- **Harsh Critic: "Theorem 4.2 conditions are heavy and not discussed interpretably" portion about the conditions being unverifiable** → Moved to Trivial weakness level; this is a presentation concern, not a substantive flaw in the theorem.

## Novel Insights
The calibration comparison surfaces a fundamental tradeoff: the paper's weighted conformal approach achieves marginal coverage (including extreme cases) at the cost of potentially wider prediction intervals, while PAC-type methods from Davidov et al. (2025) produce tighter bounds but fail on outliers. The outlier experiment (Figure 3) makes this tradeoff concrete — it shows that the distinction between exact marginal and PAC guarantees has measurable practical consequences for robustness, not merely theoretical nuance.

## Suggestions
- Fix the derivation in Equation (1) by either providing a correct equality chain or restating it as a single inequality with proper justification. If the intended step is ℙ(A|X,W) = ℙ(A,e=1|X,W)/p(e=1|X,W) followed by an inequality, state this explicitly.
- Either prove that the τ-optimization preserves the coverage guarantee, restrict the method to use a fixed τ = α, or acknowledge the optimization as a heuristic validated empirically.
- Define "Relative LPB," "Uncal," and "Naive" explicitly in the main text.
- Add at least one baseline comparison on the real clinical data, even if only in an appendix.

MY FINAL SCORE: <score>6.0</score>
MY FINAL DECISION: <decision>Accept</decision>